Zobrazeno 1 - 3
of 3
pro vyhledávání: '"Susan Natoli"'
Autor:
Erin K. O'Reilly, Amanda B. Parrish, Susan Natoli, Nancy Hassell, Jelena P. Berglund, Irwin M. Liu, Denise C. Snyder, Mark Stacy, Valerie Amspacher, Bruce K. Burnett, Jackie B. Rimmler
Publikováno v:
Clinical and Translational Science. 8:48-51
The Food and Drug Administration Amendments Act of 2007 (FDAAA 2007, US Public Law 110-98) mandated registration and reporting of results for applicable clinical trials (ACTs). Meeting these registration and results reporting requirements has proven
Autor:
Anastasia Ivanova, Beverly S. Mitchell, Marie Green, Anandhi R. Johri, Peter M. Voorhees, Hendrik W. van Deventer, Elizabeth G. Trehu, Dixie Lee Esseltine, Reynaldo Garcia, Fred J. Kudrik, Thomas C. Shea, Julian Adams, Don A. Gabriel, Celeste Lindley, Paul Jones, Melissa D. Hall, E. Claire Dees, Mary Jo Lehman, Robert Z. Orlowski, Tammy Allred, Susan Natoli, Jason M. Collins
Publikováno v:
Blood. 105:3058-3065
Proteasome inhibitors, a novel class of chemotherapeutic agents, enhance the antitumor efficacy of anthracyclines in vitro and in vivo. We therefore sought to determine the maximum tolerated dose (MTD) and dose-limiting toxicities of bortezomib and p
Publikováno v:
Clinical Lung Cancer. 2:133-138
Two recent trials have suggested that docetaxel improves survival in the second-line treatment of non small-cell lung cancer (NSCLC) refractory to first-line platinum-based regimens. Given this, it is appropriate to continue to address the role of ne